派林生物: 2024年年度股东大会决议公告

Meeting Overview - The shareholders' meeting of Pailin Biopharmaceutical Co., Ltd. was held on May 21, 2025, with both on-site and online voting options available [1][2] - All proposals presented at the meeting were approved without any rejections [1] Attendance and Voting - The meeting was attended by company directors, supervisors, and senior management, with legal representatives from Beijing Jiayuan Law Firm present to witness the proceedings [2] - The voting results showed a high level of agreement among shareholders, with significant majorities in favor of all proposals [2][3] Proposal Voting Results - Proposal 1: 2024 Annual Board Work Report received 98.5551% approval from shareholders [2] - Proposal 2: 2024 Annual Supervisory Board Work Report received 99.7636% approval [2] - Proposal 3: 2024 Annual Report and its Summary received 99.7699% approval [3] - Proposal 4: 2024 Annual Financial Settlement Report received 99.8072% approval [3] - Proposal 5: 2024 Annual Profit Distribution Plan received 98.8167% approval [3] - Proposal 6: Appointment of Directors and Senior Management received 99.6818% approval [3] Legal Opinion - The legal opinion provided by Beijing Jiayuan Law Firm confirmed that the meeting's procedures, qualifications of attendees, and voting processes complied with relevant laws and regulations [3]